Magnus Financial Group’s BioTelemetry, Inc. BEAT Stock Holding History

Magnus Financial Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,557	Closed	-$342K	–	706
2020 Q2	$342K	Sell	7,557 -447	-6%	-$20K	0.04%	294
2020 Q1	$308K	Buy	+8,004	New	+$368K	0.04%	264
2019 Q2	–	Sell	-4,078	Closed	-$255K	–	601
2019 Q1	$255K	Hold	4,078	–	–	0.05%	315
2018 Q4	$244K	Buy	+4,078	New	+$245K	0.06%	268

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Magnus Financial Group's BEAT Position: Q3 2020 in Review

Magnus Financial Group sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 7,557 shares — an estimated $342K sold.

Magnus Financial Group first reported a position in BEAT in Q4 2018 and held it in 4 quarters. The position peaked at $342K in Q2 2020. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

Magnus Financial Group reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
Magnus Financial Group sold 7,557 BioTelemetry, Inc. shares in Q3 2020, an estimated $342K.
Magnus Financial Group first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 4 quarters.
Magnus Financial Group's BioTelemetry, Inc. position peaked at $342K in Q2 2020.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Magnus Financial Group's 13F filing for Q3 2020, filed 5 Nov 2020.